Completed PHASE3 INTERVENTIONAL 3-arm NCT02831998

In-vivo Efficacy of Patient Preoperative Prep

Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZP

Sponsor: Zurex Pharma, Inc.

Interventions ChloraPrep ZP Vehicle ZuraPrep

Updated 12 times since 2017 Last updated: Feb 6, 2023 Started: Jul 27, 2016 Primary completion: Apr 9, 2017 Completion: Apr 9, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Surgical Skin Preparation, this trial is completed. The trial is conducted by Zurex Pharma, Inc. and has accumulated 12 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Mar 2023 — Jul 2024 [monthly]

Completed PHASE3
Jan 2023 — Mar 2023 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3

▶ Show 7 earlier versions

Sep 2021 — Dec 2022 [monthly]

Completed PHASE3
Jan 2021 — Sep 2021 [monthly]

Completed PHASE3
Aug 2018 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — Aug 2018 [monthly]

Completed PHASE3
Aug 2017 — Jun 2018 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Feb 2017 — Aug 2017 [monthly]

Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zurex Pharma, Inc.

Data source: Zurex Pharma, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sterling, United States